Cutaneous fungal infections remain a global health concern, with dermatophytic infections such as athlete’s foot, jock itch, and ringworm affecting millions of individuals. While luliconazole, an ...
LOS ALTOS, Calif.--(BUSINESS WIRE)--TOPICA Pharmaceuticals, Inc., a privately held biotechnology company, today announced that it’s ready to advance its 10% solution of luliconazole into Phase 3 ...
Funding to Support Phase 2b/3 Clinical Development Program of Luliconazole for the Treatment of Onychomycosis PALO ALTO, CA, Oct 18, 2011 (MARKETWIRE via COMTEX) -- TOPICA Pharmaceuticals, Inc., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results